Cita APA (7a ed.)

Willmann, S., Marostica, E., Snelder, N., Solms, A., Jensen, M., Lobmeyer, M., . . . Bhanot, S. (2021). PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients. Wiley.

Cita Chicago Style (17a ed.)

Willmann, Stefan, et al. PK/PD Modeling of FXI Antisense Oligonucleotides to Bridge the Dose‐FXI Activity Relation from Healthy Volunteers to End‐stage Renal Disease Patients. Wiley, 2021.

Cita MLA (8a ed.)

Willmann, Stefan, et al. PK/PD Modeling of FXI Antisense Oligonucleotides to Bridge the Dose‐FXI Activity Relation from Healthy Volunteers to End‐stage Renal Disease Patients. Wiley, 2021.